<unk>  is a Ophthalmologic Agent that is FDA approved for the treatment of Macular Edema Following Retinal Vein Occlusion , Diabetic Macular Edema ,Neovascular (Wet) Age-Related Macular Degeneration.   Common adverse reactions include conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, and vitreous detachment.
Aflibercept
Ziv-aflibercept
Toceranib
Ranibizumab
Avelumab
Gilteritinib
Baricitinib
Pegaptanib